Article info

Download PDFPDF

Original research
On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017

Authors

  1. Correspondence to Dr Christer Frode Aas; christer.frode.aas{at}helse-bergen.no
View Full Text

Citation

Aas CF, Vold JH, Skurtveit S, et al
On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017

Publication history

  • Received December 12, 2019
  • Revised June 22, 2020
  • Accepted July 7, 2020
  • First published August 26, 2020.
Online issue publication 
August 26, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.